Marcos R. Escobedo-Guerra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marcos R. Escobedo-Guerra has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Fernando Martin Guerra-Infante
Laboratorio de Virología del Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Ciudad de México, México
9 shared publications Marcela López-Hurtado
Laboratorio de Virología, Departamento de Infectología del Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Colonia Lomas de los Virreyes, Delegación Miguel Hidalgo, Ciudad de México, Mexico
4 shared publicationsMarcela Lopez-Hurtado
Departamento de Infectología, Instituto Nacional de Perinatología, CDMX, Mexico
3 shared publicationsGabriel Arteaga-Troncoso
2 shared publicationsMitzuko Katoku-Herrera
Departamento de Infectología, Instituto Nacional de Perinatología, CDMX, Mexico
2 shared publications- Alfredo Gabriel Torres
Department of Biomedical Sciences, School of Graduate Studies, Meharry Medical College, Nashville, USA
1 shared publication
Latest Publications
- Open Access
- 30 April 2022
- Published by Universidad Nacional Hermilio Valdizan in Revista Peruana de Investigación en Salud
- Vol. 6 (2) , 91-100
Utilidad del Cobas® Taqman® Ct Test, v2.0 para la detección de cepas de Chlamydia Trachomatis circulantes en México
Objetivo: Evaluar la utilidad de la prueba de qPCR de COBAS® TaqMan® Chlamydia trachomatis (CT) para la detección de cepas circulantes en México. Materiales y Métodos: Estudio descriptivo y transversal. Se analizaron 413 muestras endocervicales por el sistema COBAS® de pacientes con infertilidad, con el diagnóstico de C. trachomatis. que acudieron a la Clínica ETS del Instituto Nacional de Perinatología (INPer) en la Ciudad de México. Las muestras positivas también analizaron por el sistema Abbot Real-time CT / NG, y por PCR de punto final para la detección de plásmido. Las variables de estudio fueron: Infertilidad, diagnóstico de Chlamydia trachomatis, infección por Chlamydia y otras variables. Para determinar la asociación entre la infección por CT y los datos clínicos se utilizó la prueba no paramétrica exacta de Fisher. Un valor pResultados: De las 413 muestras, 276 pacientes femeninas con infertilidad primaria y 137 de infertilidad secundaria, con edades de 20 a 42 años. La principal causa de infertilidad primaria fue factor endocrino-ovárico y de infertilidad secundaria fue el factor tuboperitoneal. De 22 muestras fueron positivas, una asociación significativa entre la infertilidad por factor tubárico y la infección por C. trachomatis (RR = 2,47 IC95% 1,1-5,5, p Conclusión: El sistema de COBAS® TaqMan® CT de Roche Molecular Diagnostic mostró mayor utilidad para identificar las cepas de CT que están circulando en México.
- 30 April 2022
- Published by Universidad Nacional Hermilio Valdizan in Revista Peruana de Investigación en Salud
- Vol. 6 (2) , 91-100
Open AccessUtilidad del Cobas® Taqman® Ct Test, v2.0 para la detección de cepas de Chlamydia Trachomatis circulantes en México
Objetivo: Evaluar la utilidad de la prueba de qPCR de COBAS® TaqMan® Chlamydia trachomatis (CT) para la detección de cepas circulantes en México. Materiales y Métodos: Estudio descriptivo y transversal. Se analizaron 413 muestras endocervicales por el sistema COBAS® de pacientes con infertilidad, con el diagnóstico de C. trachomatis. que acudieron a la Clínica ETS del Instituto Nacional de Perinatología (INPer) en la Ciudad de México. Las muestras positivas también analizaron por el sistema Abbot Real-time CT / NG, y por PCR de punto final para la detección de plásmido. Las variables de estudio fueron: Infertilidad, diagnóstico de Chlamydia trachomatis, infección por Chlamydia y otras variables. Para determinar la asociación entre la infección por CT y los datos clínicos se utilizó la prueba no paramétrica exacta de Fisher. Un valor pResultados: De las 413 muestras, 276 pacientes femeninas con infertilidad primaria y 137 de infertilidad secundaria, con edades de 20 a 42 años. La principal causa de infertilidad primaria fue factor endocrino-ovárico y de infertilidad secundaria fue el factor tuboperitoneal. De 22 muestras fueron positivas, una asociación significativa entre la infertilidad por factor tubárico y la infección por C. trachomatis (RR = 2,47 IC95% 1,1-5,5, p Conclusión: El sistema de COBAS® TaqMan® CT de Roche Molecular Diagnostic mostró mayor utilidad para identificar las cepas de CT que están circulando en México.
- 30 September 2020
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 31 (13) , 1255-1262
Co-infection between genotypes of the human papillomavirus and Chlamydia trachomatis in Mexican women
Not all human papillomavirus (HPV) infections develop into cervical cancer (CC), so it is proposed that other factors may influence this, such as co-infection with Chlamydia trachomatis (CT). To identify the prevalence of co-infection, we included 189 women with suspicion of HPV. Viral typing was performed by carrying out the Roche HP Linear Array test, while CT detection was performed with the COBAS® TaqMan® 48 kit from Roche. Of the 189 women only 184 had an infection with HPV, CT or both: 56.6% were positive for one or several HPV genotypes, and 67.7% for CT. Clinical data showed an association between HPV and CIN I (n = 22; RR = 2.43; 95% CI 1.72–3.43, p < 0.05). CT infection was only associated with cervicitis (n = 40; RR = 1.73; 95% CI 1.34–2.23, p < 0.05). The CT-HPV co-infection rate was 28%. Co-infection revealed an association with CIN I (n = 31, RR= 3.33; 95% CI 2.08–5.34 p < 0.05), CIN III (n = 7; RR = 2.57; 95% CI 1.53–4.31, p < 0.05); and a significant risk of 2.3 (95% CI 1.08–4.90) times higher to develop CC; nevertheless, this risk was not statistically significant. CT/HPV co-infection was associated with the development of a high-grade lesion (CIN III) as well as an important risk for developing CC.
- 30 September 2020
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 31 (13) , 1255-1262
Co-infection between genotypes of the human papillomavirus and Chlamydia trachomatis in Mexican women
Not all human papillomavirus (HPV) infections develop into cervical cancer (CC), so it is proposed that other factors may influence this, such as co-infection with Chlamydia trachomatis (CT). To identify the prevalence of co-infection, we included 189 women with suspicion of HPV. Viral typing was performed by carrying out the Roche HP Linear Array test, while CT detection was performed with the COBAS® TaqMan® 48 kit from Roche. Of the 189 women only 184 had an infection with HPV, CT or both: 56.6% were positive for one or several HPV genotypes, and 67.7% for CT. Clinical data showed an association between HPV and CIN I (n = 22; RR = 2.43; 95% CI 1.72–3.43, p < 0.05). CT infection was only associated with cervicitis (n = 40; RR = 1.73; 95% CI 1.34–2.23, p < 0.05). The CT-HPV co-infection rate was 28%. Co-infection revealed an association with CIN I (n = 31, RR= 3.33; 95% CI 2.08–5.34 p < 0.05), CIN III (n = 7; RR = 2.57; 95% CI 1.53–4.31, p < 0.05); and a significant risk of 2.3 (95% CI 1.08–4.90) times higher to develop CC; nevertheless, this risk was not statistically significant. CT/HPV co-infection was associated with the development of a high-grade lesion (CIN III) as well as an important risk for developing CC.
- 11 April 2019
- Published by Springer Nature in International Microbiology
- Vol. 22 (4) , 471-478
Obtaining an ELISA test based on a recombinant protein of Chlamydia trachomatis
Chlamydia trachomatis is considered as a public health problem due to its high prevalence and increased rates of gynecological disorders. The major outer membrane protein (MOMP) of this bacterium is the most abundant protein in its membrane and has been evaluated not only as a vaccine development candidate but also is used in many diagnostic tests. The MOMP weighs 69 kDa and contains four variable segments (VS 1–4) separated by constant regions. Several research groups have developed recombinant single-variable segments of MOMP expressed in Escherichia coli cytoplasm. But, all variable segments have been used minimally for the diagnosis of a chlamydial infection. In this experiment, the authors obtained the recombinant MOMP of C. trachomatis (rMOMP) in E. coli rMOMP and extracted, purified, and partially characterized it. This was later used to identify anti-Chlamydia trachomatis antibodies in sera of infertile patients by immunodetection assays, enzyme-linked immunosorbent assay (ELISA), and indirect immunofluorescence tests. The ELISA test showed high sensitivity and low specificity of 100 and 58.3%, respectively. The above results obtained were linked to the cross-reactivity of antibodies against C. pneumoniae or C. psittaci. Hence, an evaluation was performed to obtain an optimized test for the diagnosis of C. trachomatis infection.
- 11 April 2019
- Published by Springer Nature in International Microbiology
- Vol. 22 (4) , 471-478
Obtaining an ELISA test based on a recombinant protein of Chlamydia trachomatis
Chlamydia trachomatis is considered as a public health problem due to its high prevalence and increased rates of gynecological disorders. The major outer membrane protein (MOMP) of this bacterium is the most abundant protein in its membrane and has been evaluated not only as a vaccine development candidate but also is used in many diagnostic tests. The MOMP weighs 69 kDa and contains four variable segments (VS 1–4) separated by constant regions. Several research groups have developed recombinant single-variable segments of MOMP expressed in Escherichia coli cytoplasm. But, all variable segments have been used minimally for the diagnosis of a chlamydial infection. In this experiment, the authors obtained the recombinant MOMP of C. trachomatis (rMOMP) in E. coli rMOMP and extracted, purified, and partially characterized it. This was later used to identify anti-Chlamydia trachomatis antibodies in sera of infertile patients by immunodetection assays, enzyme-linked immunosorbent assay (ELISA), and indirect immunofluorescence tests. The ELISA test showed high sensitivity and low specificity of 100 and 58.3%, respectively. The above results obtained were linked to the cross-reactivity of antibodies against C. pneumoniae or C. psittaci. Hence, an evaluation was performed to obtain an optimized test for the diagnosis of C. trachomatis infection.
- 1 February 2019
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 37 (2) , 93-99
Identification of a new variant of Chlamydia trachomatis in Mexico
- 1 February 2019
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 37 (2) , 93-99
Identification of a new variant of Chlamydia trachomatis in Mexico
- Open Access
- 18 January 2019
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 6 (2) , ofz008
Misidentification of Burkholderia pseudomallei and Other Burkholderia Species From Pediatric Infections in Mexico
Burkholderia pseudomallei and Burkholderia cepacia complex are poorly studied in Mexico. The genotypic analysis of 38 strains isolated from children with pneumonia were identified and showed that both Burkholderia groups were present in patients. From our results, it is plausible to suggest that new species are among the analyzed strains.
- 18 January 2019
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 6 (2) , ofz008
Open AccessMisidentification of Burkholderia pseudomallei and Other Burkholderia Species From Pediatric Infections in Mexico
Burkholderia pseudomallei and Burkholderia cepacia complex are poorly studied in Mexico. The genotypic analysis of 38 strains isolated from children with pneumonia were identified and showed that both Burkholderia groups were present in patients. From our results, it is plausible to suggest that new species are among the analyzed strains.
- Open Access
- 1 August 2018
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista chilena de infectología
- Vol. 35 (4) , 371-376
Prevalencia de la infección genital por Chlamydia trachomatis en mujeres que asisten al Instituto Nacional de Perinatología de la Ciudad de México
Palabras clave: Chlamydia trachomatis; prevalencia; embarazo; adolescentes; México
- 1 August 2018
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista chilena de infectología
- Vol. 35 (4) , 371-376
Open AccessPrevalencia de la infección genital por Chlamydia trachomatis en mujeres que asisten al Instituto Nacional de Perinatología de la Ciudad de México
Palabras clave: Chlamydia trachomatis; prevalencia; embarazo; adolescentes; México
- 1 June 2018
- Published by Springer Nature in Molecular Diagnosis & Therapy
- Vol. 22 (3) , 361-368
Use of the mtrR Gene for Rapid Molecular Diagnosis of Neisseria gonorrhoeae and Identification of the Reduction of Susceptibility to Antibiotics in Endocervical Swabs
Background Neisseria gonorrhoeae is one of the main etiological agents of sexually transmitted diseases. The asymptomatic course of the infection and its resistance to antibiotics can lead to pelvic inflammatory disease and infertility. Objectives We developed a polymerase chain reaction (PCR) test using the methyltetrahydrofolate homocysteine methyltransferase reductase (mtrR) gene to identify N. gonorrhoeae and detect reduced susceptibility to antibiotics. Material and Methods We analysed 250 samples of endocervical exudate from infertile women with a negative diagnosis of N. gonorrhoeae. We designed NGmtr primers to detect N. gonorrhoeae and identify the antibiotic-resistant strain. Results Of the 250 samples, 60 (24%) tested positive for N. gonorrhoeae using real-time PCR. Our study was validated using the HO primers and the Seeplex STD6 ACE System, with a 100% correlation. Furthermore, the NGmtr primers are specific for N. gonorrhoeae and not for other species. Additionally, the curves generated by real-time PCR differed between wild and variant strains (10.93%). The dissociation temperatures for the wild and variant strains were 86.5 and 89 degrees C, respectively. Conclusions The NGmtr primers enabled us to identify N. gonorrhoeae strains with or without reduction of susceptibility to antibiotics. Therefore, this work constitutes a tool that will facilitate the diagnosis of this infection for a low cost and improve patient quality of life.
- 1 June 2018
- Published by Springer Nature in Molecular Diagnosis & Therapy
- Vol. 22 (3) , 361-368
Use of the mtrR Gene for Rapid Molecular Diagnosis of Neisseria gonorrhoeae and Identification of the Reduction of Susceptibility to Antibiotics in Endocervical Swabs
Background Neisseria gonorrhoeae is one of the main etiological agents of sexually transmitted diseases. The asymptomatic course of the infection and its resistance to antibiotics can lead to pelvic inflammatory disease and infertility. Objectives We developed a polymerase chain reaction (PCR) test using the methyltetrahydrofolate homocysteine methyltransferase reductase (mtrR) gene to identify N. gonorrhoeae and detect reduced susceptibility to antibiotics. Material and Methods We analysed 250 samples of endocervical exudate from infertile women with a negative diagnosis of N. gonorrhoeae. We designed NGmtr primers to detect N. gonorrhoeae and identify the antibiotic-resistant strain. Results Of the 250 samples, 60 (24%) tested positive for N. gonorrhoeae using real-time PCR. Our study was validated using the HO primers and the Seeplex STD6 ACE System, with a 100% correlation. Furthermore, the NGmtr primers are specific for N. gonorrhoeae and not for other species. Additionally, the curves generated by real-time PCR differed between wild and variant strains (10.93%). The dissociation temperatures for the wild and variant strains were 86.5 and 89 degrees C, respectively. Conclusions The NGmtr primers enabled us to identify N. gonorrhoeae strains with or without reduction of susceptibility to antibiotics. Therefore, this work constitutes a tool that will facilitate the diagnosis of this infection for a low cost and improve patient quality of life.
- Open Access
- 1 March 2014
- Published by Elsevier in Jornal de Pediatria
- Vol. 90 (2) , 182-189
Reporting detection of Chlamydia trachomatis DNA in tissues of neonatal death cases
- 1 March 2014
- Published by Elsevier in Jornal de Pediatria
- Vol. 90 (2) , 182-189
Open AccessReporting detection of Chlamydia trachomatis DNA in tissues of neonatal death cases
- 1 February 2011
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 29 (2) , 102-108
Genotyping of Chlamydia trachomatis from endocervical specimens of infertile Mexican women
- 1 February 2011
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 29 (2) , 102-108
Genotyping of Chlamydia trachomatis from endocervical specimens of infertile Mexican women
- 15 January 2009
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 127 (1-2) , 181-185
Evaluation of endocytic capacity and NADPH-oxidase activity from armadillo (Dasypus novemcinctus) eosinophils infected with microfilariae
- 15 January 2009
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 127 (1-2) , 181-185
Evaluation of endocytic capacity and NADPH-oxidase activity from armadillo (Dasypus novemcinctus) eosinophils infected with microfilariae